IFP Advisors, Inc - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 140 filers reported holding HERON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2792710.00%
Q2 2021$0
-100.0%
0
-100.0%
0.00%
Q1 2021$3,000
+200.0%
200
+376.2%
0.00%
Q4 2020$1,000420.00%
Q3 2020$000.00%
Q2 2020$000.00%
Q1 2020$000.00%
Q4 2019$000.00%
Q3 2019$00
-100.0%
0.00%
Q4 2018$0
-100.0%
14
-94.1%
0.00%
Q3 2018$8,0000.0%239
+11.7%
0.00%
Q2 2018$8,000214
+21300.0%
0.00%
Q4 2016$010.0%0.00%
Q3 2016$01
-91.7%
0.00%
Q2 2016$012
+9.1%
0.00%
Q4 2015$0110.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANG KEVIN C 760$1,900100.00%
Velan Capital Investment Management LP 2,500,000$6,250,0005.52%
GREAT POINT PARTNERS LLC 6,360,161$15,900,4033.12%
Cheyne Capital Management (UK) LLP 318,008$795,0201.39%
TANG CAPITAL MANAGEMENT LLC 3,755,934$9,389,8351.36%
Rubric Capital Management LP 11,750,000$29,375,0001.28%
Orchard Capital Management, LLC 1,391,080$3,477,7001.17%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 267,028$667,5700.81%
CM Management, LLC 250,000$6250.75%
Tejara Capital Ltd 493,619$1,234,0480.71%
View complete list of HERON THERAPEUTICS INC shareholders